Cargando…

Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients

BACKGROUND: Surgical site infection (SSI) is one of the most common sources of morbidity after pancreaticoduodenectomy. Surgical site infections are associated with readmissions, prolonged length of stay, delayed initiation of adjuvant chemotherapy and negative effects on quality of life. Incisional...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Brittany, Lagrotteria, Andrew, Tsang, Melanie E., Jayaraman, Shiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609889/
https://www.ncbi.nlm.nih.gov/pubmed/37875305
http://dx.doi.org/10.1503/cjs.000723
_version_ 1785128120984010752
author Greene, Brittany
Lagrotteria, Andrew
Tsang, Melanie E.
Jayaraman, Shiva
author_facet Greene, Brittany
Lagrotteria, Andrew
Tsang, Melanie E.
Jayaraman, Shiva
author_sort Greene, Brittany
collection PubMed
description BACKGROUND: Surgical site infection (SSI) is one of the most common sources of morbidity after pancreaticoduodenectomy. Surgical site infections are associated with readmissions, prolonged length of stay, delayed initiation of adjuvant chemotherapy and negative effects on quality of life. Incisional vacuum-assisted closure (iVAC) devices applied on closed incisions may reduce SSI rates. The objective of this retrospective review is to evaluate the impact of iVAC on SSI rate after pancreaticoduodenectomy. METHODS: A cohort of patients undergoing pancreaticoduodenectomy at a single institution who had at least 1 risk factor for SSI and who received an iVAC were compared with a historical cohort of high-risk patients who received conventional dressings after pancreaticoduodenectomy. The primary outcome was incidence of SSI within 30 days, abstracted from chart review. Secondary outcomes were 30-day readmission, 90-day mortality, rate of postoperative pancreatic fistula and rate of delayed gastric emptying. RESULTS: In total, 175 patients were included, of whom 61 received an iVAC. The incidence of SSI was 13% (8 of 61 patients) and 16% (18 of 114 patients) in the iVAC and conventional dressing groups, respectively (odds ratio 0.81, 95% confidence interval 0.33–1.98). Preoperative biliary drainage was the most frequent SSI risk factor. Binary logistic regression using SSI as the outcome demonstrated no significant association with iVAC use when adjusted for SSI risk factors. There were no differences in rates of postoperative pancreatic fistula, delayed gastric emptying or 90-day mortality. CONCLUSION: This report describes the outcomes of the integration of iVAC devices into routine clinical practice at a high-volume institution. Application of this device after pancreaticoduodenectomy for patients at elevated risk of SSI was not associated with a reduction in the rate of SSIs.
format Online
Article
Text
id pubmed-10609889
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-106098892023-10-28 Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients Greene, Brittany Lagrotteria, Andrew Tsang, Melanie E. Jayaraman, Shiva Can J Surg Research BACKGROUND: Surgical site infection (SSI) is one of the most common sources of morbidity after pancreaticoduodenectomy. Surgical site infections are associated with readmissions, prolonged length of stay, delayed initiation of adjuvant chemotherapy and negative effects on quality of life. Incisional vacuum-assisted closure (iVAC) devices applied on closed incisions may reduce SSI rates. The objective of this retrospective review is to evaluate the impact of iVAC on SSI rate after pancreaticoduodenectomy. METHODS: A cohort of patients undergoing pancreaticoduodenectomy at a single institution who had at least 1 risk factor for SSI and who received an iVAC were compared with a historical cohort of high-risk patients who received conventional dressings after pancreaticoduodenectomy. The primary outcome was incidence of SSI within 30 days, abstracted from chart review. Secondary outcomes were 30-day readmission, 90-day mortality, rate of postoperative pancreatic fistula and rate of delayed gastric emptying. RESULTS: In total, 175 patients were included, of whom 61 received an iVAC. The incidence of SSI was 13% (8 of 61 patients) and 16% (18 of 114 patients) in the iVAC and conventional dressing groups, respectively (odds ratio 0.81, 95% confidence interval 0.33–1.98). Preoperative biliary drainage was the most frequent SSI risk factor. Binary logistic regression using SSI as the outcome demonstrated no significant association with iVAC use when adjusted for SSI risk factors. There were no differences in rates of postoperative pancreatic fistula, delayed gastric emptying or 90-day mortality. CONCLUSION: This report describes the outcomes of the integration of iVAC devices into routine clinical practice at a high-volume institution. Application of this device after pancreaticoduodenectomy for patients at elevated risk of SSI was not associated with a reduction in the rate of SSIs. CMA Impact Inc. 2023-10-24 /pmc/articles/PMC10609889/ /pubmed/37875305 http://dx.doi.org/10.1503/cjs.000723 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Greene, Brittany
Lagrotteria, Andrew
Tsang, Melanie E.
Jayaraman, Shiva
Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title_full Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title_fullStr Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title_full_unstemmed Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title_short Closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
title_sort closed incision negative pressure wound therapy following pancreaticoduodenectomy for prevention of surgical site infections in high-risk patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609889/
https://www.ncbi.nlm.nih.gov/pubmed/37875305
http://dx.doi.org/10.1503/cjs.000723
work_keys_str_mv AT greenebrittany closedincisionnegativepressurewoundtherapyfollowingpancreaticoduodenectomyforpreventionofsurgicalsiteinfectionsinhighriskpatients
AT lagrotteriaandrew closedincisionnegativepressurewoundtherapyfollowingpancreaticoduodenectomyforpreventionofsurgicalsiteinfectionsinhighriskpatients
AT tsangmelaniee closedincisionnegativepressurewoundtherapyfollowingpancreaticoduodenectomyforpreventionofsurgicalsiteinfectionsinhighriskpatients
AT jayaramanshiva closedincisionnegativepressurewoundtherapyfollowingpancreaticoduodenectomyforpreventionofsurgicalsiteinfectionsinhighriskpatients